vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $17.6M, roughly 1.1× AVITA Medical, Inc.). Arteris, Inc. runs the higher net margin — -42.2% vs -66.0%, a 23.7% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs -4.3%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 24.7%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

AIP vs RCEL — Head-to-Head

Bigger by revenue
AIP
AIP
1.1× larger
AIP
$20.1M
$17.6M
RCEL
Growing faster (revenue YoY)
AIP
AIP
+34.3% gap
AIP
30.0%
-4.3%
RCEL
Higher net margin
AIP
AIP
23.7% more per $
AIP
-42.2%
-66.0%
RCEL
More free cash flow
AIP
AIP
$9.1M more FCF
AIP
$3.0M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
24.7%
AIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIP
AIP
RCEL
RCEL
Revenue
$20.1M
$17.6M
Net Profit
$-8.5M
$-11.6M
Gross Margin
90.8%
81.2%
Operating Margin
-42.0%
-59.1%
Net Margin
-42.2%
-66.0%
Revenue YoY
30.0%
-4.3%
Net Profit YoY
-3.7%
-0.3%
EPS (diluted)
$-0.19
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
RCEL
RCEL
Q4 25
$20.1M
$17.6M
Q3 25
$17.4M
$17.1M
Q2 25
$16.5M
$18.4M
Q1 25
$16.5M
$18.5M
Q4 24
$15.5M
$18.4M
Q3 24
$14.7M
$19.5M
Q2 24
$14.6M
$15.2M
Q1 24
$12.9M
$11.1M
Net Profit
AIP
AIP
RCEL
RCEL
Q4 25
$-8.5M
$-11.6M
Q3 25
$-9.0M
$-13.2M
Q2 25
$-9.1M
$-9.9M
Q1 25
$-8.1M
$-13.9M
Q4 24
$-8.2M
$-11.6M
Q3 24
$-7.7M
$-16.2M
Q2 24
$-8.3M
$-15.4M
Q1 24
$-9.4M
$-18.7M
Gross Margin
AIP
AIP
RCEL
RCEL
Q4 25
90.8%
81.2%
Q3 25
89.9%
81.3%
Q2 25
89.4%
81.2%
Q1 25
90.8%
84.7%
Q4 24
89.8%
87.6%
Q3 24
90.1%
83.7%
Q2 24
90.0%
86.1%
Q1 24
88.7%
86.4%
Operating Margin
AIP
AIP
RCEL
RCEL
Q4 25
-42.0%
-59.1%
Q3 25
-50.1%
-53.6%
Q2 25
-50.0%
-60.5%
Q1 25
-46.6%
-63.9%
Q4 24
-45.9%
-54.1%
Q3 24
-53.8%
-70.6%
Q2 24
-51.1%
-102.8%
Q1 24
-70.5%
-155.0%
Net Margin
AIP
AIP
RCEL
RCEL
Q4 25
-42.2%
-66.0%
Q3 25
-51.6%
-77.3%
Q2 25
-55.3%
-53.9%
Q1 25
-49.1%
-74.9%
Q4 24
-53.0%
-63.0%
Q3 24
-52.2%
-82.9%
Q2 24
-57.2%
-101.3%
Q1 24
-72.6%
-168.0%
EPS (diluted)
AIP
AIP
RCEL
RCEL
Q4 25
$-0.19
$-0.37
Q3 25
$-0.21
$-0.46
Q2 25
$-0.22
$-0.38
Q1 25
$-0.20
$-0.53
Q4 24
$-0.19
$-0.44
Q3 24
$-0.20
$-0.62
Q2 24
$-0.22
$-0.60
Q1 24
$-0.25
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$33.9M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$-16.6M
Total Assets
$115.0M
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
RCEL
RCEL
Q4 25
$33.9M
$18.2M
Q3 25
$39.0M
$23.3M
Q2 25
$38.0M
$15.7M
Q1 25
$42.3M
$25.8M
Q4 24
$43.8M
$35.9M
Q3 24
$48.7M
$44.4M
Q2 24
$45.8M
$54.1M
Q1 24
$44.8M
$68.2M
Stockholders' Equity
AIP
AIP
RCEL
RCEL
Q4 25
$-14.6M
$-16.6M
Q3 25
$-11.4M
$-6.7M
Q2 25
$-7.5M
$-12.9M
Q1 25
$-4.8M
$-4.6M
Q4 24
$-1.2M
$4.5M
Q3 24
$2.2M
$12.2M
Q2 24
$5.3M
$23.9M
Q1 24
$9.5M
$32.6M
Total Assets
AIP
AIP
RCEL
RCEL
Q4 25
$115.0M
$56.4M
Q3 25
$107.7M
$63.7M
Q2 25
$106.9M
$58.1M
Q1 25
$98.3M
$69.6M
Q4 24
$106.1M
$79.7M
Q3 24
$97.7M
$81.1M
Q2 24
$96.4M
$87.8M
Q1 24
$101.4M
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
RCEL
RCEL
Operating Cash FlowLast quarter
$3.2M
$-5.4M
Free Cash FlowOCF − Capex
$3.0M
$-6.1M
FCF MarginFCF / Revenue
15.1%
-34.7%
Capex IntensityCapex / Revenue
0.7%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
RCEL
RCEL
Q4 25
$3.2M
$-5.4M
Q3 25
$3.2M
$-5.2M
Q2 25
$-2.5M
$-10.2M
Q1 25
$2.9M
$-10.3M
Q4 24
$-2.6M
$-8.1M
Q3 24
$1.1M
$-7.2M
Q2 24
$311.0K
$-12.8M
Q1 24
$477.0K
$-20.9M
Free Cash Flow
AIP
AIP
RCEL
RCEL
Q4 25
$3.0M
$-6.1M
Q3 25
$2.5M
$-6.2M
Q2 25
$-2.8M
$-10.8M
Q1 25
$2.7M
$-10.5M
Q4 24
$-2.7M
$-9.7M
Q3 24
$1.1M
$-11.0M
Q2 24
$264.0K
$-15.4M
Q1 24
$281.0K
$-22.0M
FCF Margin
AIP
AIP
RCEL
RCEL
Q4 25
15.1%
-34.7%
Q3 25
14.2%
-36.1%
Q2 25
-17.2%
-58.4%
Q1 25
16.2%
-56.9%
Q4 24
-17.3%
-52.7%
Q3 24
7.4%
-56.1%
Q2 24
1.8%
-101.6%
Q1 24
2.2%
-198.2%
Capex Intensity
AIP
AIP
RCEL
RCEL
Q4 25
0.7%
3.8%
Q3 25
4.1%
5.5%
Q2 25
2.2%
2.8%
Q1 25
1.1%
1.2%
Q4 24
0.3%
8.8%
Q3 24
0.2%
19.2%
Q2 24
0.3%
17.5%
Q1 24
1.5%
10.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

RCEL
RCEL

Segment breakdown not available.

Related Comparisons